By Laura Lovett 11:59 am September 1, 2020
This marks the first automated delivery system that can be used for children 2 to 6. 
By Dave Muoio 11:15 am September 1, 2020
The company said it has grown its business by 400% in the last three months alone.
By Dave Muoio 03:04 pm August 31, 2020
Also: Abbott sells 150 million of its rapid, app-paired COVID-19 test to the White House; Platform launches for chronic disease patients juggling multiple providers.
By Laura Lovett 03:03 pm August 31, 2020
Masimo's O3 Regional Oximeter can be integrated with its SedLine brain function monitor or its Root patient monitoring and connectivity platform. 
By Dave Muoio 01:40 pm August 31, 2020
The new analysis of a Pear Therapeutics-based randomized controlled trial came alongside another investigation that spotted early signs of treatment dropout.
By Laura Lovett 01:28 pm August 31, 2020
The company was founded in 2011 and is looking to go public on the Nasdaq market. 
By Mallory Hackett 12:12 pm August 31, 2020
More people experienced high blood pressure in response to the COVID-19 pandemic compared to before, according to new research from chronic care management company Livongo. The study looked at the proportion of Livongo members who had high blood pressure before and during the pandemic, specifically covering the time between mid-September of 2019 and mid-August of 2020.
By Laura Lovett 01:46 pm August 28, 2020
A new report from PitchBook projects solid growth in the industry, but also notes challenges in exits. 
By Mallory Hackett 12:40 pm August 28, 2020
Following a study looking into how adults living with Type 2 diabetes use technology to self-monitor lifestyle and health behaviors, researchers from the University of Texas Health Science Center at San Antonio found that technology-assisted self-monitoring was safe and effective in generating positive health outcomes.
By Laura Lovett 11:19 am August 28, 2020
The paper discusses the potenital for collecting real-world data, recruiting patients and using APIs.